Deletion of a decoy epitope in porcine circovirus 2 (PCV2) capsid protein affects the protective immune response in mice

• Published in: Archives of virology Vol. 165; no. 12; pp. 2829 - 2835
• Main Authors: Kim, Kiju, Shin, Minna, Hahn, Tae-Wook
• Format: Journal Article
• Language: English
• Published: Vienna Springer Vienna 01.12.2020; Springer Nature B.V
• Subjects: Antibodies; Baculoviridae; Biomedical and Life Sciences; Biomedicine; capsid; Capsid protein; coat proteins; Epitopes; Immune response; Immunization; Immunoglobulin G; Infectious Diseases; information; Medical Microbiology; mice; Mutants; neutralization; neutralizing antibodies; Original Article; pathogens; Porcine circovirus-2; Proteins; swine; vaccine development; Virology; Virus-like particles
• ISSN: 0304-8608; 1432-8798; 1432-8798
• DOI: 10.1007/s00705-020-04831-z

The swine pathogen porcine circovirus type 2 (PCV2) causes significant economic damage worldwide. The PCV2 capsid (CP) residues 169-STIDYFQPNNKR-180 have been identified as a decoy epitope that diverts the host immune response away from protective epitopes. However, the decoy epitope may include important linear or conformational protective epitopes against PCV2. In this study, we used the baculovirus system to express recombinant complete CP (1–233) and mutant CP (Δ169–180), in which the decoy epitope was deleted, and evaluated the immune response to these in mice. Immunization with mutant CP (Δ169–180) protein, which formed very low level of virus-like particles (VLPs), elicited significantly lower levels of PCV2 CP-specific IgG antibodies and a slightly lower neutralizing activity than immunization with the complete CP (1–233) protein. This finding suggests that the complete CP is important for efficient VLP assembly and induction of PCV2-specific IgG antibodies and neutralizing antibodies in mice. This study may provide useful information for next-generation vaccine design for PCV2 control.